Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AMI Holdings (American Medical Instruments Holdings, Inc.) was a prominent medical device holding company that specialized in the acquisition and operation of niche manufacturers in the interventional radiology, ophthalmology, and surgical markets. As a portfolio company of RoundTable Healthcare Partners, it consolidated several leading brands, including Inter-V, Surgical Specialties, and Point Technologies, to offer a comprehensive portfolio of specialty needles, biopsy devices, and wound closure products. The company operated through two primary units: Inter-V, focused on vascular access and interventional radiology, and Surgical Specialties, focused on ophthalmic and wound closure devices. In 2006, AMI Holdings was acquired by Angiotech Pharmaceuticals for approximately $785 million, significantly expanding Angiotech's manufacturing footprint and product offerings in the interventional medicine space.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AMI Holdings.